These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1068197)

  • 21. High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.
    Hata M; Tsuzuki M; Goto Y; Kumagai N; Harada M; Hashimoto M; Tanaka S; Sakae K; Kimura T; Minagawa H; Miyazaki Y
    Jpn J Infect Dis; 2007 Jul; 60(4):202-4. PubMed ID: 17642534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(50):308. PubMed ID: 16503051
    [No Abstract]   [Full Text] [Related]  

  • 23. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.
    Abed Y; Bourgault AM; Fenton RJ; Morley PJ; Gower D; Owens IJ; Tisdale M; Boivin G
    J Infect Dis; 2002 Oct; 186(8):1074-80. PubMed ID: 12355356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraepidemic heterogeneity of influenza A (H3N2) viruses in 1985: antigenic analysis and sensitivity to non-specific inhibitors.
    Pyhälä R; Pyhälä L; Visakorpi R
    Med Biol; 1986; 64(5):277-84. PubMed ID: 3807442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
    Baz M; Paskel M; Matsuoka Y; Zengel JR; Cheng X; Treanor JJ; Jin H; Subbarao K
    J Virol; 2015 Jul; 89(13):6907-17. PubMed ID: 25903333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombination of influenza A virus strains: effect on pathogenicity.
    Ennis FA; Verbonitz M; Reichelderfer P; Daniel S
    Dev Biol Stand; 1976; 33():220-5. PubMed ID: 955268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets.
    Sweet C; Hayden FG; Jakeman KJ; Grambas S; Hay AJ
    J Infect Dis; 1991 Nov; 164(5):969-72. PubMed ID: 1940477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
    Zaraket H; Saito R; Wakim R; Tabet C; Medlej F; Reda M; Baranovich T; Suzuki Y; Dapat C; Caperig-Dapat I; Dbaibo GS; Suzuki H
    J Med Virol; 2010 Jul; 82(7):1224-8. PubMed ID: 20513088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.
    Rahman M; Hoque SA; Islam MA; Rahman SR
    Virus Genes; 2017 Jun; 53(3):377-385. PubMed ID: 28401407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012.
    Cai J; Wang X; Zhao B; Yao W; Wang X; Zhu Q; Zeng M
    J Med Virol; 2014 Jun; 86(6):1026-33. PubMed ID: 24523140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
    Deyde VM; Xu X; Bright RA; Shaw M; Smith CB; Zhang Y; Shu Y; Gubareva LV; Cox NJ; Klimov AI
    J Infect Dis; 2007 Jul; 196(2):249-57. PubMed ID: 17570112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations.
    Abed Y; Goyette N; Boivin G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):556-9. PubMed ID: 15673732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan.
    Saito R; Suzuki Y; Li D; Zaraket H; Sato I; Masaki H; Kawashima T; Hibi S; Sano Y; Shobugawa Y; Oguma T; Suzuki H
    J Infect Dis; 2008 Feb; 197(4):630-2; author reply 632-3. PubMed ID: 18275281
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of development of resistance to antivirals in the ferret model of influenza virus infection.
    Herlocher ML; Truscon R; Fenton R; Klimov A; Elias S; Ohmit SE; Monto AS
    J Infect Dis; 2003 Nov; 188(9):1355-61. PubMed ID: 14593594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.
    Katz JM; Webster RG
    J Infect Dis; 1989 Aug; 160(2):191-8. PubMed ID: 2760480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
    Cheng H; Wan J; Lin MI; Liu Y; Lu X; Liu J; Xu Y; Chen J; Tu Z; Cheng YS; Ding K
    J Med Chem; 2012 Mar; 55(5):2144-53. PubMed ID: 22332894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.